This paper briefly summarizes the development of magnetic resonance imaging and spectroscopy in medicine.Aspects of magnetic resonancephysics and-technology relevant at ultra-high magnetic fields as well as current li...This paper briefly summarizes the development of magnetic resonance imaging and spectroscopy in medicine.Aspects of magnetic resonancephysics and-technology relevant at ultra-high magnetic fields as well as current limitations are highlighted.Based on the first promising studies,potential clinical applications at 7 Tesla are suggested.Other aims are to stimulate awareness of the potential of ultra-high field magnetic resonance and to stimulate active participation in much needed basic or clinical research at 7 Tesla or higher.展开更多
目的观察依达拉奉对急性脑梗死患者磁共振氢质子波谱(1H magnetic resonance spectroscopy,1H MRS)的影响,评价依达拉奉治疗急性脑梗死的疗效。方法选择发病24h内的急性脑梗死患者66例,随机分为依达拉奉组(35例)及对照组(31例)。对2组...目的观察依达拉奉对急性脑梗死患者磁共振氢质子波谱(1H magnetic resonance spectroscopy,1H MRS)的影响,评价依达拉奉治疗急性脑梗死的疗效。方法选择发病24h内的急性脑梗死患者66例,随机分为依达拉奉组(35例)及对照组(31例)。对2组治疗前及4周后美国国立卫生研究院脑卒中量表评分(NIHSS评分)、N-乙酰天冬氨酸(NAA),N-乙酰天冬氨酸与肌酸(Cr)比值(NAA/Cr)进行比较。结果4周后依达拉奉组NIHSS评分(5.71±1.74)较对照组(7.26±2.87)降低明显,差异有统计学意义(P<0.05)。4周后NAA、NAA/Cr值对照组(514±118、1.67±0.23)和依达拉奉组(613±169、1.82±0.28)均较治疗前(对照组345±108、1.34±0.18;治疗组336±115、1.32±0.19)升高,但依达拉奉组升高明显,差异有统计学意义(P<0.05)。结论依达拉奉是一种有效的治疗急性脑梗死的神经保护剂。展开更多
In the present study we investigated structural and metabolic modifications of the brain in the Ts65Dn mouse model of Down syndrome(DS)using both in vivo magnetic resonance imaging(MRI)and proton magnetic resonance sp...In the present study we investigated structural and metabolic modifications of the brain in the Ts65Dn mouse model of Down syndrome(DS)using both in vivo magnetic resonance imaging(MRI)and proton magnetic resonance spectroscopy(MRS). MRI was performed for further texture analysis and changes in texture parameters, including mean grey levels, contrast and homogeneity, and they were found in Ts65Dn compared to diploid littermates (2n). These phenotypic changes were different in the hippocampus and cerebellum, since in Ts65Dn mean grey levels increased in the cerebellum and decreased in the hippocampus. In addition, proton NMR spectra revealed differences in metabolite ratios. Levels of N-acetylaspartate(NAA)and glutamate(Glu), were lower compared to total creatine levels (CX), in the Ts65Dn brain. However, the most striking finding was an increase in the concentration of myo-inositol(Ins)and choline(Cho)in the hippocampus, whereas the Ins concentration was reduced in the cerebellum. Overall, these data illustrate that MRI and MRS are valuable assesment tools sufficiently sensitive to detect associated changes in different brain areas, thus providing new insight into the causative role of dosage-sensitive genes in the Ts65Dn DS mouse model.展开更多
文摘This paper briefly summarizes the development of magnetic resonance imaging and spectroscopy in medicine.Aspects of magnetic resonancephysics and-technology relevant at ultra-high magnetic fields as well as current limitations are highlighted.Based on the first promising studies,potential clinical applications at 7 Tesla are suggested.Other aims are to stimulate awareness of the potential of ultra-high field magnetic resonance and to stimulate active participation in much needed basic or clinical research at 7 Tesla or higher.
文摘目的观察依达拉奉对急性脑梗死患者磁共振氢质子波谱(1H magnetic resonance spectroscopy,1H MRS)的影响,评价依达拉奉治疗急性脑梗死的疗效。方法选择发病24h内的急性脑梗死患者66例,随机分为依达拉奉组(35例)及对照组(31例)。对2组治疗前及4周后美国国立卫生研究院脑卒中量表评分(NIHSS评分)、N-乙酰天冬氨酸(NAA),N-乙酰天冬氨酸与肌酸(Cr)比值(NAA/Cr)进行比较。结果4周后依达拉奉组NIHSS评分(5.71±1.74)较对照组(7.26±2.87)降低明显,差异有统计学意义(P<0.05)。4周后NAA、NAA/Cr值对照组(514±118、1.67±0.23)和依达拉奉组(613±169、1.82±0.28)均较治疗前(对照组345±108、1.34±0.18;治疗组336±115、1.32±0.19)升高,但依达拉奉组升高明显,差异有统计学意义(P<0.05)。结论依达拉奉是一种有效的治疗急性脑梗死的神经保护剂。
文摘In the present study we investigated structural and metabolic modifications of the brain in the Ts65Dn mouse model of Down syndrome(DS)using both in vivo magnetic resonance imaging(MRI)and proton magnetic resonance spectroscopy(MRS). MRI was performed for further texture analysis and changes in texture parameters, including mean grey levels, contrast and homogeneity, and they were found in Ts65Dn compared to diploid littermates (2n). These phenotypic changes were different in the hippocampus and cerebellum, since in Ts65Dn mean grey levels increased in the cerebellum and decreased in the hippocampus. In addition, proton NMR spectra revealed differences in metabolite ratios. Levels of N-acetylaspartate(NAA)and glutamate(Glu), were lower compared to total creatine levels (CX), in the Ts65Dn brain. However, the most striking finding was an increase in the concentration of myo-inositol(Ins)and choline(Cho)in the hippocampus, whereas the Ins concentration was reduced in the cerebellum. Overall, these data illustrate that MRI and MRS are valuable assesment tools sufficiently sensitive to detect associated changes in different brain areas, thus providing new insight into the causative role of dosage-sensitive genes in the Ts65Dn DS mouse model.
